Process mining software vendor Minit seals funding

Bratislava-based Minit, a process mining software vendor, has secured 3.3 million euros in funding. The investors were Earlybird Venture Capital and OTB Ventures. PRESS RELEASE [Bratislava /Dec. 13, 2018] – Process Mining Software vendor Minit today announces that it has received €3.3 million in venture funding from Earlybird Venture Capital and OTB Ventures. The company plans to use the funding to grow its team in R&D, sales, marketing, and consultancy, as well as to facilitate expansion into global markets. Minit develops Process Mining Software that visualizes how complex business processes really happen in order to provide transparency into process variants and resource usage, as well as how they can be improved. This helps companies streamline their manufacturing and financial procedures as well as other business-critical processes like bank loan approvals and insurance claim processing. It also provides an effective way to ensure and document process compliance internally
Continue reading "Process mining software vendor Minit seals funding"

Synthace raises $25.6 mln Series B

London-based Synthace Ltd, a developer of a cloud software platform for automating and improving the success rate of biological research and development, has secured $25.6 million in Series B funding. Horizons Ventures led the round with participation from other investors that included Luminous Ventures and SOSV. PRESS RELEASE 12 December – LONDON – Synthace Ltd., the company behind the leading cloud software platform for automating and improving the success rate of biological research and development, today announced the closing of a $25.6m Series B financing round led by Horizons Ventures with additional investment from Luminous Ventures, SOSV and select other individual and large family office investors. Synthace will use the new funds to drive continued product development and build upon its cell and gene therapy customer base to accelerate global awareness of its solutions. Synthace is a leader in Computer Aided Biology, a new paradigm that
Continue reading "Synthace raises $25.6 mln Series B"

Mission Bio rallies $30 mln Series B

South San Francisco-based Mission Bio Inc, a provider of single-cell DNA analysis and precision genomics solutions, has secured $30 million in Series B funding. The investors were Agilent Technologies, Cota Capital, LAM Capital and Mayfield. PRESS RELEASE SOUTH SAN FRANCISCO, Calif. (December 13, 2018)– Mission Bio, Inc., the pioneer in single-cell DNA analysis and precision genomics, today announced it raised $30 million in Series B funding from Agilent Technologies (NYSE: A), Cota Capital, LAM Capital, and Mayfield, bringing the total amount raised by the company to more than $50 million. The funds will scale its unique single-cell DNA technology, the Tapestri® Platform, by expanding the market for blood cancer research, while at the same time broadening its scope to CRISPR applications and extending into global markets. Single-Cell Genomics, a Key to Precision Medicine
Identifying precision cancer treatments often involves broad-based next-generation sequencing (NGS). This method provides an average
Continue reading "Mission Bio rallies $30 mln Series B"

Hi Fidelity Genetics reels in $8.5 mln Series A

Durham, North Carolina-based Hi Fidelity Genetics, a computational crop breeding company, has raised $8.5 million in Series A financing. Fall Line Capital and Finistere Ventures led the round with participation from Gro Alliance, KdT Ventures, Prairie Crest Capital, S2G and Tom Farms. Source: Press Release

Guru snaps up $25 mln Series B

Philadelphia and San Francisco-based Guru, a revenue empowerment network, has raised $25 million in Series B funding. Thrive Capital led the round with participation from return backers Emergence Capital, FirstMark Capital, Slack Fund and Michael Dell’s MSD Capital. Source: Press Release

Celect inks $15 mln Series C

Boston-based Celect, a provider of predictive analytics and inventory optimization for retailers, has raised $15 million in Series C financing. NGP Capital and Fung Capital led the round with participation from Activant Capital and August Capital. Source: Press Release

Inscribe gathers $3 mln seed

San Francisco and Dublin-based Inscribe, a company that automates the process of identifying fraudulent documents using image forensics and machine learning, has secured $3 million in seed financing. Crosslink Capital and Uncork Capital led the round. PRESS RELEASE San Francisco, December 13, 2018 – Inscribe, a company that automates the process of identifying fraudulent documents using a combination of image forensics and machine learning, has secured $3M in seed funding after graduating from Y Combinator. Crosslink Capital and Uncork Capital led the round with participation from SV Angel, Liquid 2 Ventures, Quiet Capital, Friále, and angel investors Marc McCabe and Brad Flora. Prior to this, Inscribe raised $170,000 from Y Combinator and Acceleprise. “Document fraud affects almost every industry and sector – from financial services and insurance to governments and marketplaces. Any organization that requires detailed information from documents such as bank statements, utility bills or invoices before making
Continue reading "Inscribe gathers $3 mln seed"

Zymergen locks in $400 mln Series C

Emeryville, California-based Zymergen, a molecular manufacturing technology company, has raised over $400 million in Series C funding. SoftBank Vision Fund led the round with participation from Goldman Sachs, Hanwha Asset Management, DCVC, True Ventures, Two Sigma Ventures, DFJ and Innovation Endeavors. Source: Press Release

JUMO takes in $12.5 mln

JUMO, a fintech company, has secured $12.5 million in funding. The investor was Odey Asset Management. In conjunction with the funding, James Hanbury, a partner at Odey Asset Management, joined the JUMO board. Source: Press Release

Vyng fetches $4 mln Series A

Los Angeles-based Vyng, a mobile conversation startup, has raised $4 million in Series A funding. Omidyar Network India and March Capital Partners led the round with participation from Alpha Edison and the Entrepreneur Fund. Source: Press Release

Black Diamond to set up shop in Toronto with $20 mln round

Black Diamond Therapeutics, a Stony Brook, New York-based cancer precision medicine platform, has emerged from stealth with a $20 million Series A financing. The round was backed by life sciences venture capital firm Versant Ventures. The company will use a share of the proceeds to set up operations in Toronto, giving it access to the city’s pool of computing talent. Black Diamond, the first startup launched out of Versant’s Swiss discovery engine, is developing precision medicines directed against allosteric mutant oncogenes. PRESS RELEASE BASEL, Switzerland & TORONTO–(BUSINESS WIRE)–Black Diamond Therapeutics, a biotechnology company developing a new type of precision medicine for cancer, came out of stealth mode today with a $20 million Series A financing exclusively from founding investor Versant Ventures. Black Diamond is the first company launched out of Ridgeline, Versant’s Discovery Engine based in Basel, Switzerland, and has a unique platform capable of prosecuting allosteric mutant oncogenes.
Continue reading "Black Diamond to set up shop in Toronto with $20 mln round"

Tigera gathers $30 mln Series B

San Francisco-based Tigera, an enterprise software company providing security and compliance solutions for Kubernetes platforms, has secured $30 million in Series B funding. Insight Venture Partners led the round with participation from return Madrona, NEA and Wing. Source: Press Release